CJC-1295 + Ipamorelin

CJC-1295 + Ipamorelin Blend combines a growth hormone-releasing hormone (GHRH) analog with a selective growth hormone secretagogue (GHS) for synergistic GH axis stimulation. CJC-1295 (without DAC) extends GHRH signaling while Ipamorelin selectively activates the ghrelin receptor (GHS-R1a) without affecting cortisol or prolactin.

Blend Composition:

• CJC-1295 (No DAC): GHRH analog (Modified GRF 1-29)
• Ipamorelin: Selective GHS-R1a agonist pentapeptide

Research Applications:

• Synergistic GH pulse amplitude and frequency studies
• IGF-1 axis modulation without cortisol elevation
• Body composition and lean mass research
• Sleep architecture and GH secretion pattern analysis
• Age-related GH decline countermeasure studies

Quality Standards:

• Each component: ≥99% purity verified by HPLC
• Third-party tested with COA included

FOR RESEARCH USE ONLY. Not for human consumption.